ArticlePloS one2025
Evaluation of hospital-acquired conditions reduction program in surgical procedures.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hospital-Acquired Conditions Reduction Program (HACRP) by the Centers for Medicare & Medicaid (CMS) penalizes hospitals in the worst quartile of performance for targeted hospital-acquired conditions (HAC). This study examines its impacts on two targeted conditions: surgical site infection (SSI) for abdominal hysterectomy and colon procedures. This paper used a quasi-experimental method of difference-in-differences (DID) to analyze the National (Nationwide) Inpatient Sample (NIS) from January 2012 to September 2015. The DID models compared changes in the probability of SSI for the targeted and control procedures before and after HACRP implementation. The DID estimates could be interpreted as the impact of the program. All models controlled for patient and hospital characteristics. The DID estimates were insignificant, and the results were robust across various sensitivity analyses. Although the results suggest that HACRP had no direct impact on SSIs in the two targeted conditions, caution should be exercised when interpreting these conclusions. This study is exploratory, and future research is needed to address its limitations, including the low predictive value of administrative SSI codes and concerns regarding the comparability of the control group. Previous studies have proposed three areas to improve HACRP: better measurement design, improved communication and follow-up, and alternative penalty structure. Collecting more granular data and conducting in-person interviews in future studies could help validate the current findings and identify effective strategies for improving HACRP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.